AS
Ataman, Sebnem
22 papers · 182 citations · 2021–2026
Publications
22
Citations
182
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
|
2026 | Article | 0 |
|
Gender-related Differences in Peripheral and Axial Spondyloarthritis
|
2025 | Meeting Abstract | 0 |
|
Clinical characteristics of peripheral joint disease in axial and peripheral spondyloarthritis: findings from a multicentre cross-sectional study
|
2025 | Article | 1 |
|
Factors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis
|
2025 | Article | 0 |
|
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
|
2025 | Article | 2 |
|
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry
|
2024 | Article | 8 |
|
Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study
|
2024 | Article | 19 |
|
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
|
2024 | Article | 2 |
|
Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry
|
2024 | Article | 6 |
|
The impact of nail psoriasis on disease activity, quality of life, and clinical variables in patients with psoriatic arthritis: A cross-sectional multicenter study
|
2023 | Article | 9 |
|
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
|
2023 | Article | 10 |
|
Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study
|
2023 | Article | 5 |
|
Familial Mediterranean fever: perspective on female fertility and disease course in pregnancy from a multicenter nationwide network
|
2023 | Article | 4 |
|
Beyond expectations: disease duration and psychological burden in psoriatic arthritis
|
2023 | Article | 10 |
|
Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
|
2022 | Article | 3 |
|
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
|
2022 | Article | 3 |
|
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR
|
2021 | Article | 5 |
|
Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort
|
2021 | Article | 15 |
|
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
|
2021 | Article | 12 |
|
Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: A multi-center study
|
2021 | Article | 40 |
|
Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs
|
2021 | Article | 6 |
|
The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis
|
2021 | Review | 22 |